Enhanced Antigiardial Effect of Omeprazole Analog Benzimidazole Compounds

Autor: Ernesto Calderón-Jaimes, Edson Jiovany Ramírez-Nava, Beatriz Hernández-Ochoa, Saúl Gómez-Manzo, Jaime Marcial-Quino, Roberto Arreguín-Espinosa, Alfonso Méndez-Tenorio, Miguel Cuevas-Cruz, Luz María Rocha-Ramírez, Araceli Santos-Segura, Adrián Sánchez-Carrillo
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Drug Evaluation
Preclinical

Pharmaceutical Science
Pharmacology
Analytical Chemistry
Triosephosphate isomerase
chemistry.chemical_compound
Drug Discovery
Omeprazole
media_common
chemistry.chemical_classification
omeprazole analogs
0303 health sciences
Cell Death
Circular Dichroism
inhibition enzyme
Molecular Docking Simulation
Chemistry (miscellaneous)
Molecular Medicine
HT29 Cells
medicine.drug
Triose-Phosphate Isomerase
Drug
Benzimidazole
Cell Survival
media_common.quotation_subject
Antiprotozoal Agents
macromolecular substances
Article
lcsh:QD241-441
03 medical and health sciences
lcsh:Organic chemistry
medicine
Humans
Lansoprazole
Trophozoites
giardiacidal compounds
Physical and Theoretical Chemistry
TE buffer
IC50
030304 developmental biology
030306 microbiology
Organic Chemistry
In vitro
Enzyme Activation
Kinetics
giardiasis
Enzyme
Spectrometry
Fluorescence

chemistry
Drug Design
Benzimidazoles
Caco-2 Cells
Giardia lamblia
Zdroj: Molecules
Volume 25
Issue 17
Molecules, Vol 25, Iss 3979, p 3979 (2020)
ISSN: 1420-3049
Popis: Giardiasis is a diarrheal disease that is highly prevalent in developing countries. Several drugs are available for the treatment of this parasitosis
however, failures in drug therapy are common, and have adverse effects and increased resistance of the parasite to the drug, generating the need to find new alternative treatments. In this study, we synthesized a series of 2-mercaptobenzimidazoles that are derivatives of omeprazole, and the chemical structures were confirmed through mass, 1H NMR, and 13C NMR techniques. The in vitro efficacy compounds against Giardia, as well as its effect on the inhibition of triosephosphate isomerase (TPI) recombinant, were investigated, the inactivation assays were performed with 0.2 mg/mL of the enzyme incubating for 2 h at 37 °
C in TE buffer, pH 7.4 with increasing concentrations of the compounds. Among the target compounds, H-BZM2, O2N-BZM7, and O2N-BZM9 had greater antigiardial activity (IC50: 36, 14, and 17 µ
M on trophozoites), and inhibited the TPI enzyme (K2: 2.3, 3.2, and 2.8 M&minus
1 s&minus
1) respectively, loading alterations on the secondary structure, global stability, and tertiary structure of the TPI protein. Finally, we demonstrated that it had low toxicity on Caco-2 and HT29 cells. This finding makes it an attractive potential starting point for new antigiardial drugs.
Databáze: OpenAIRE